X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (615) 615
Publication (41) 41
Book Review (17) 17
Book Chapter (13) 13
Book / eBook (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (298) 298
animals (241) 241
index medicus (171) 171
alkylating agents (140) 140
oncology (110) 110
dna (107) 107
mice (99) 99
alkylating-agents (87) 87
male (86) 86
alkylating agents - pharmacology (85) 85
biochemistry & molecular biology (85) 85
cancer (80) 80
alkylation (79) 79
female (75) 75
pharmacology & pharmacy (70) 70
dna repair (68) 68
dna damage (67) 67
antineoplastic agents, alkylating - therapeutic use (66) 66
antineoplastic agents, alkylating - pharmacology (62) 62
dna - metabolism (62) 62
toxicology (62) 62
chemotherapy (57) 57
hematology (53) 53
nucleosides (51) 51
chemistry (48) 48
antineoplastic agents, alkylating - administration & dosage (47) 47
dna - chemistry (46) 46
dose-response relationship, drug (44) 44
chemistry, medicinal (43) 43
alkylating agents - toxicity (42) 42
antineoplastic agents - therapeutic use (41) 41
middle aged (41) 41
rats (41) 41
antineoplastic combined chemotherapy protocols - therapeutic use (40) 40
in-vitro (40) 40
kinetics (40) 40
mutation (39) 39
research (39) 39
aged (38) 38
cell line, tumor (35) 35
genetics & heredity (35) 35
structure-activity relationship (35) 35
alkylating agents - therapeutic use (34) 34
analysis (34) 34
antineoplastic agents - pharmacology (34) 34
apoptosis (34) 34
antineoplastic agents, alkylating - chemistry (33) 33
care and treatment (33) 33
article (32) 32
cell survival - drug effects (32) 32
chemistry, multidisciplinary (31) 31
drug resistance (31) 31
neoplasms - drug therapy (31) 31
adducts (30) 30
dna - drug effects (30) 30
fludarabine (30) 30
nucleotides (30) 30
rituximab (30) 30
treatment outcome (30) 30
apoptosis - drug effects (29) 29
dna adducts (29) 29
methylation (29) 29
molecular structure (29) 29
chemistry, organic (28) 28
deoxyribonucleic acid--dna (28) 28
dna repair - drug effects (28) 28
tumor cells, cultured (28) 28
antineoplastic agents, alkylating - adverse effects (27) 27
carcinogens (27) 27
cell line (27) 27
health aspects (27) 27
repair (27) 27
time factors (27) 27
adult (26) 26
chemical phenomena (26) 26
chronic lymphocytic-leukemia (26) 26
cells, cultured (25) 25
chlorambucil (25) 25
drug synergism (25) 25
alkylating agents - chemistry (24) 24
antineoplastic agents (24) 24
chromatography, high pressure liquid (24) 24
leukemia, lymphocytic, chronic, b-cell - drug therapy (24) 24
pyrimidines (24) 24
base sequence (23) 23
biotechnology & applied microbiology (23) 23
drugs (23) 23
hydrolysis (23) 23
vidarabine - analogs & derivatives (23) 23
clinical trials as topic (22) 22
escherichia-coli (22) 22
mutagens (22) 22
tumors (22) 22
binding sites (21) 21
cyclophosphamide (21) 21
cytotoxicity (21) 21
proteins (21) 21
alkylating agents - metabolism (20) 20
cricetinae (20) 20
enzymes (20) 20
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (612) 612
Russian (5) 5
German (4) 4
French (2) 2
Spanish (2) 2
Hungarian (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Experimental Hematology, ISSN 0301-472X, 2012, Volume 40, Issue 10, pp. 800 - 810
Hematopoietic stem cell transplantation is used for treatment of lymphoma. In an attempt to design an efficacious and safe prehematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Advanced Basic Science | CLOFARABINE | MEDICINE, RESEARCH & EXPERIMENTAL | RIBONUCLEOTIDE REDUCTASE | REPAIR | INHIBITION | DAILY INTRAVENOUS BUSULFAN | DOUBLE-STRAND BREAKS | ATM | HEMATOLOGY | FLUDARABINE | MOLECULAR-MECHANISMS | TRANSPLANTATION | Melphalan - agonists | Busulfan - agonists | Humans | Antineoplastic Agents, Alkylating - pharmacology | Deoxycytidine - pharmacology | Antineoplastic Agents, Alkylating - agonists | Deoxycytidine - agonists | Transplantation, Homologous | DNA (Cytosine-5-)-Methyltransferases - metabolism | DNA-Binding Proteins - metabolism | Dose-Response Relationship, Drug | Lymphoma - metabolism | Lymphoma - therapy | Lymphoma - pathology | Epigenesis, Genetic - drug effects | Melphalan - pharmacology | Transplantation Conditioning - methods | Hydroxamic Acids - pharmacology | Protein-Serine-Threonine Kinases - metabolism | Busulfan - pharmacology | Tumor Suppressor Proteins - metabolism | Drug Screening Assays, Antitumor - methods | Cell Cycle Proteins - metabolism | Hematopoietic Stem Cell Transplantation | Azacitidine - analogs & derivatives | Ataxia Telangiectasia Mutated Proteins | Azacitidine - agonists | Drug Synergism | Azacitidine - pharmacology | Cytotoxins | Hydroxamic Acids - agonists | Cell Line, Tumor | Checkpoint Kinase 2 | Cell Proliferation - drug effects | Deoxycytidine - analogs & derivatives | Antimitotic agents | Methyltransferases | Analysis | Nucleosides | Lymphomas | Transplantation | Antineoplastic agents | Methylation | Hematopoietic stem cells | SAHA | drug cytotoxicity Category | Hematological Malignancies or Stem Cell Transplantation | nucleoside analog | lymphoma | DNA alkylator
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2015, Volume 90, Issue 1, pp. 56 - 61
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 07/2014, Volume 55, Issue 7, pp. 1625 - 1634
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 5/2012, Volume 53, Issue 5
Hematopoietic stem cell transplantation (HSCT) is a promising treatment for lymphomas. Its success depends on effective pre-transplant conditioning regimens.... 
busulfan | DNA alkylating agent | SAHA | gemcitabine | clofarabine | lymphoma
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 07/2014, Volume 53, Issue 27, pp. 7001 - 7005
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2010, Volume 64, Issue 2, pp. 352 - 404
Sézary syndrome (SS) has a poor prognosis and few guidelines for optimizing therapy. The US Cutaneous Lymphoma Consortium, to improve clinical care of patients... 
Dermatology | Sézary syndrome | PEGYLATED LIPOSOMAL DOXORUBICIN | PHASE-II TRIAL | LOW-DOSE METHOTREXATE | Sezary syndrome | COMBINED-MODALITY THERAPY | PURINE NUCLEOSIDE PHOSPHORYLASE | BONE-MARROW-TRANSPLANTATION | ELECTRON-BEAM THERAPY | CHRONIC LYMPHOCYTIC-LEUKEMIA | T-CELL LYMPHOMA | ADVANCED MYCOSIS-FUNGOIDES | DERMATOLOGY | Sezary Syndrome - immunology | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Combined Modality Therapy | Methotrexate - therapeutic use | Evidence-Based Medicine | Alkylating Agents - therapeutic use | Mycosis Fungoides - pathology | Retinoids - therapeutic use | Mycosis Fungoides - therapy | Sezary Syndrome - therapy | Quality of Life | Histone Deacetylase Inhibitors - therapeutic use | Drug Therapy, Combination | Sezary Syndrome - pathology | Immunologic Factors - therapeutic use | Medical colleges | Care and treatment | Leukemia | Interferon alpha | Mycoses | Transplantation | Non-Hodgkin's lymphomas | Research | Biological response modifiers | T cells | Hematopoietic stem cells | Consortia | Alkaloids | Interleukins | Formulae, receipts, prescriptions | Physiological aspects | Methotrexate | Health aspects | Dendritic cells | Oncology, Experimental | Coumarins | Dermatologic agents | Transforming growth factors | Preventive health services | Monoclonal antibodies | Nucleosides | Medicine, Preventive | Interferon gamma | Cancer
Journal Article
Blood, ISSN 0006-4971, 05/2006, Volume 107, Issue 9, pp. 3442 - 3446
Journal Article